New treatments based on biological molecules like RNA give scientists unprecedented control over how cells function. But ...

Planners are keeping the bayshore city’s elevated flood risk in mind as they formulate a vision for what downtown and the surrounding area will look like over the next quarter of a century. “Very soon ...

If the Trump White House is serious about its push to make medicines more affordable, it should ensure CMS officials never ...

Before Canada decides to rely on foreign drug regulators to approve new medicines, Health Canada needs to show that it will ...

We asked certified financial planners, investment advisers and other money experts their thoughts on stock choices this year ...

The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development process for industry and patients. Our two companies are applying AI in ...

Novo Nordisk's CagriSema could be a brand new growth driver for the company. Eli Lilly's orforglipron is breaking into a new, lucrative market. One of these companies should lead this market, but both ...

A new project seeking to transform the drug delivery process and take projects out of “the valley of death” between aspiration and accomplishment is getting help from La Jolla-based medical research ...

The drug targets a specific mutation that applies to only 2% of ALS patients. A new drug may slow progression of -- and even reverse -- symptoms of a rare form of amyotrophic lateral sclerosis, or ALS ...

Less than six months after a series A fundraise, AI drug developer Chai Discovery has brewed up a $130 million series B to further energize development of its “computer-aided design suite” for new ...

Dec 8 (Reuters) - The U.S. Food and Drug Administration has qualified the first artificial intelligence tool designed to help doctors assess a severe form of fatty liver disease in drug trials, the ...

The FDA has qualified its first artificial intelligence tool to help drug developers evaluate fatty liver disease in their clinical trials. The agency gave a green light to the AI-Based Histologic ...